• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喀麦隆雅温得疟疾的分子流行病学。III. 恶性疟原虫多药耐药1(pfmdr 1)基因的氯喹耐药性及点突变分析

Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum.

作者信息

Basco L K, Ringwald P

机构信息

Institut Français de Recherche Scientifique pour le Développement en Coopération (ORSTOM) and Laboratoire de Recherches sur le Paludisme, Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale, Yaoundé, Cameroon.

出版信息

Am J Trop Med Hyg. 1998 Oct;59(4):577-81. doi: 10.4269/ajtmh.1998.59.577.

DOI:10.4269/ajtmh.1998.59.577
PMID:9790433
Abstract

It has been postulated that chloroquine resistance may be associated with a single point mutation at codon 86 of the Plasmodium falciparum multidrug resistance 1 (pfmdr 1) gene. Using a simple and rapid molecular technique involving polymerase chain reaction and restriction fragment length polymorphism, the frequency of the Asn-to-Tyr mutation associated with chloroquine resistance was established among 129 clinical isolates obtained from indigenous patients in Yaoundé, Cameroon. The results showed that 110 of 129 isolates display a mutant codon. The other clinical isolates had either a pure wild-type Asn-86 codon (n = 12) or mixed Asn/Tyr alleles (n = 7). In vitro drug assays were performed to compare the genotype and phenotype in 102 clinical isolates. Of these isolates, 86 displayed pure Tyr-86 mutant codon; 48 (56%) mutant isolates were chloroquine-resistant (50% inhibitory concentration [IC50] > 100 nM), as expected, but 38 (44%) mutant isolates were chloroquine-sensitive (IC50 < 100 nM). Three chloroquine-resistant isolates and seven chloroquine-sensitive parasites carried a wild-type Asn-86 codon. Mixed alleles were found in six isolates (four chloroquine-sensitive and two chloroquine-resistant isolates). Our results did not confirm previous observations on the possible association between chloroquine resistance phenotype and genotype based on the pfmdr 1 gene.

摘要

据推测,氯喹抗性可能与恶性疟原虫多药抗性1(pfmdr 1)基因第86密码子的单点突变有关。利用一种涉及聚合酶链反应和限制性片段长度多态性的简单快速分子技术,在从喀麦隆雅温得的本地患者中获得的129份临床分离株中确定了与氯喹抗性相关的天冬酰胺到酪氨酸突变的频率。结果显示,129份分离株中有110份显示突变密码子。其他临床分离株要么具有纯野生型天冬酰胺-86密码子(n = 12),要么具有混合的天冬酰胺/酪氨酸等位基因(n = 7)。对102份临床分离株进行了体外药物试验以比较基因型和表型。在这些分离株中,86份显示纯酪氨酸-86突变密码子;正如预期的那样,48份(56%)突变分离株对氯喹耐药(50%抑制浓度[IC50] > 100 nM),但38份(44%)突变分离株对氯喹敏感(IC50 < 100 nM)。三份氯喹耐药分离株和七份氯喹敏感寄生虫携带野生型天冬酰胺-86密码子。在六份分离株(四份氯喹敏感和两份氯喹耐药分离株)中发现了混合等位基因。我们的结果未证实先前基于pfmdr 1基因对氯喹抗性表型和基因型之间可能关联的观察结果。

相似文献

1
Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum.喀麦隆雅温得疟疾的分子流行病学。III. 恶性疟原虫多药耐药1(pfmdr 1)基因的氯喹耐药性及点突变分析
Am J Trop Med Hyg. 1998 Oct;59(4):577-81. doi: 10.4269/ajtmh.1998.59.577.
2
Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.喀麦隆雅温得疟疾的分子流行病学 I. 恶性疟原虫二氢叶酸还原酶-胸苷酸合成酶基因点突变分析
Am J Trop Med Hyg. 1998 Mar;58(3):369-73. doi: 10.4269/ajtmh.1998.58.369.
3
Strong association, but incomplete correlation, between chloroquine resistance and allelic variation in the pfmdr-1 gene of Plasmodium falciparum isolates from India.
Ann Trop Med Parasitol. 1999 Oct;93(7):679-84. doi: 10.1080/00034989957916.
4
Molecular epidemiology of malaria in Yaounde, Cameroon V. analysis of the omega repetitive region of the plasmodium falciparum CG2 gene and chloroquine resistance.喀麦隆雅温得疟疾的分子流行病学 V. 恶性疟原虫CG2基因ω重复区域分析与氯喹抗性
Am J Trop Med Hyg. 1999 Nov;61(5):807-13. doi: 10.4269/ajtmh.1999.61.807.
5
[The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province].[从海南省分离的恶性疟原虫中Pfcrt和Pfmdr1基因的点突变]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Jun 30;23(3):135-9.
6
Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.氯喹停用后大科摩罗岛恶性疟原虫分离株中crt和mdr-1突变的流行情况
Malar J. 2016 Aug 15;15(1):414. doi: 10.1186/s12936-016-1474-4.
7
Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.
J Trop Pediatr. 2007 Feb;53(1):27-31. doi: 10.1093/tropej/fml076. Epub 2006 Dec 10.
8
Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda.乌干达坎帕拉恶性疟原虫pfcrt和pfmdr - 1基因多态性与氯喹临床反应
J Infect Dis. 2001 May 1;183(9):1417-20. doi: 10.1086/319865. Epub 2001 Mar 27.
9
Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia.
Am J Trop Med Hyg. 1999 Aug;61(2):240-4. doi: 10.4269/ajtmh.1999.61.240.
10
Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaoundé, Cameroon.喀麦隆雅温得关键疟原虫氯喹抗性转运蛋白(pfcrt)点突变分析及其对氯喹的体内外反应
J Infect Dis. 2001 Jun 15;183(12):1828-31. doi: 10.1086/320726. Epub 2001 May 16.

引用本文的文献

1
Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.在印度尼西亚将双氢青蒿素-哌喹作为治疗无并发症恶性疟的一线抗疟治疗药物引入后,耐药性遗传标记的演变。
Malar J. 2023 Aug 9;22(1):231. doi: 10.1186/s12936-023-04658-4.
2
Ten-Year Molecular Surveillance of Drug-Resistant spp. Isolated From the China-Myanmar Border.十年间中缅边境地区耐多药 分离株的分子监测
Front Cell Infect Microbiol. 2021 Sep 1;11:733788. doi: 10.3389/fcimb.2021.733788. eCollection 2021.
3
Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998-2020).
抗疟药在喀麦隆疗效演变中的耐药标志物:系统评价和荟萃分析(1998-2020 年)。
Malar J. 2021 Jan 9;20(1):32. doi: 10.1186/s12936-020-03543-8.
4
High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.青蒿素高水平耐药伴奎宁交叉耐药在体内青蒿琥酯压力下出现在恶性疟原虫疟疾中。
BMC Med. 2018 Oct 1;16(1):181. doi: 10.1186/s12916-018-1156-x.
5
Role of Different Pfcrt and Pfmdr-1 Mutations in Conferring Resistance to Antimalaria Drugs in Plasmodium falciparum.不同的恶性疟原虫氯喹抗性转运蛋白(Pfcrt)和疟原虫多药耐药蛋白1(Pfmdr-1)突变在恶性疟原虫对抗疟药物产生抗性中的作用
Malar Res Treat. 2014;2014:950424. doi: 10.1155/2014/950424. Epub 2014 Nov 11.
6
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.Pfmdr1在恶性疟原虫对氯喹、奎宁、单去乙基氨喹啉、甲氟喹、本芴醇和双氢青蒿素的体外易感性中的作用。
Antimicrob Agents Chemother. 2014 Dec;58(12):7032-40. doi: 10.1128/AAC.03494-14. Epub 2014 Sep 8.
7
Does malaria epidemiology project Cameroon as 'Africa in miniature'?疟疾流行病学是否将喀麦隆视为“非洲缩影”?
J Biosci. 2014 Sep;39(4):727-38. doi: 10.1007/s12038-014-9451-y.
8
In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene.体外吡喹酮敏感性与恶性疟原虫氯喹耐药转运蛋白基因无关。
Malar J. 2013 Nov 25;12:431. doi: 10.1186/1475-2875-12-431.
9
Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.乙胺嘧啶/磺胺多辛与氯喹治疗5岁以下儿童单纯性恶性疟的疗效比较
Iran J Parasitol. 2013 Jan;8(1):1-17.
10
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.2010 年塞内加尔达喀尔地区恶性疟原虫对抗疟药物的敏感性:一项离体和耐药分子标志物研究。
Malar J. 2013 Mar 20;12:107. doi: 10.1186/1475-2875-12-107.